Latest tumor Stories
Studies Using Caris Molecular Intelligence(TM) Identify Standard as well as Novel Therapeutic Options Based on Molecular Characterization of Individual Patients' Tumors IRVING, Texas,
Market Size - $448 million in 2013, Market Growth - CAGR of 26.2%, Market Trends - Growing commercialization rates in Asia Pacific - Latest report published by Grand View Research.
Radiosurgery-guided procedure could offer hope for patients with benign and cancerous brain tumors CHICAGO, Dec.
Based on the results of the trial's pre-specified interim analysis all control patients in the EF-14 phase III trial will be offered the opportunity to cross over to receive Tumor Treating Fields
CARLSBAD, Calif., Nov. 20, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Late-Breaker Oral Presentation Highlights Favorable Safety, Tolerability and Pharmacokinetic Profile for TVB-2640 BARCELONA, Spain, Nov.
The order in which a proposed new treatment combination is administered to mesothelioma patients appears to impact effectiveness and tumor regrowth. Raleigh,
- Data include results from a Phase 1 study of ABT-414 as monotherapy and in combination with radiation and/or chemotherapy in patients with newly diagnosed and recurrent/unresectable glioblastoma
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.